Cumberland Pharmaceuticals Ownership 2024 | Who Owns Cumberland Pharmaceuticals Now?


OverviewRevenueFinancialsChartTranscripts

Institutional Ownership

8.50%

Insider Ownership

44.47%

Retail Ownership

47.03%

Institutional Holders

9.00

Cumberland Pharmaceuticals Institutional Shareholders


Institutional Shareholders by % of Total Shares

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
RENAISSANCE TECHNOLOGIES LLC3.82%0.00%538,163-4,500-0.83%823,389Jun 30, 2024
VANGUARD GROUP INC2.65%-374,251--572,604Jun 30, 2024
DIMENSIONAL FUND ADVISORS LP2.16%0.00%304,109-53,506-14.96%465,287Jun 30, 2024
BRIDGEWAY CAPITAL MANAGEMENT, LLC2.03%0.01%286,655--438,582Jun 30, 2024
ACADIAN ASSET MANAGEMENT LLC1.33%0.00%188,164--286,000Jun 30, 2024
BLACKROCK INC.0.78%-110,564--169,163Jun 30, 2024
GEODE CAPITAL MANAGEMENT, LLC0.63%-88,7464,2245.00%135,801Jun 30, 2024
BANK OF NEW YORK MELLON CORP0.53%-75,268--115,160Jun 30, 2024
STATE STREET CORP0.24%-33,700--51,561,000Jun 30, 2024
CRESSET ASSET MANAGEMENT, LLC0.15%0.00%21,0259,00074.84%32,168Jun 30, 2024
TWO SIGMA INVESTMENTS, LP0.14%0.00%19,330-13,100-40.39%29,575Jun 30, 2024
NORTHERN TRUST CORP0.12%-16,322-16-0.10%24,973,000Jun 30, 2024
UBS GROUP AG0.05%-6,8705,077283.16%10,511Jun 30, 2024
TOWER RESEARCH CAPITAL LLC (TRC)0.05%0.00%6,60886114.98%10,110Jun 30, 2024
OAKWORTH CAPITAL, INC.0.02%0.00%3,052--4,670Jun 30, 2024
MORGAN STANLEY0.02%-2,660-8,614-76.41%4,070Jun 30, 2024
INNEALTA CAPITAL, LLC0.01%0.00%948948100.00%1,450Jun 30, 2024
ADVISOR GROUP HOLDINGS, INC.0.00%-100--153Jun 30, 2024
BANK OF AMERICA CORP /DE/0.00%-6767100.00%103Jun 30, 2024
JPMORGAN CHASE & CO0.00%-20--31Jun 30, 2024

Cumberland Pharmaceuticals's largest institutional shareholder is RENAISSANCE TECHNOLOGIES LLC, holding 3.82% of the company's total share outstanding, currently valued at $823.39K. The top 10 institutional shareholders own together 14.33% of the company.

Institutional Shareholders by % of Total Assets

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
BRIDGEWAY CAPITAL MANAGEMENT, LLC2.03%0.01%286,655--438,582Jun 30, 2024
RENAISSANCE TECHNOLOGIES LLC3.82%0.00%538,163-4,500-0.83%823,389Jun 30, 2024
ACADIAN ASSET MANAGEMENT LLC1.33%0.00%188,164--286,000Jun 30, 2024
INNEALTA CAPITAL, LLC0.01%0.00%948948100.00%1,450Jun 30, 2024
OAKWORTH CAPITAL, INC.0.02%0.00%3,052--4,670Jun 30, 2024
TOWER RESEARCH CAPITAL LLC (TRC)0.05%0.00%6,60886114.98%10,110Jun 30, 2024
CRESSET ASSET MANAGEMENT, LLC0.15%0.00%21,0259,00074.84%32,168Jun 30, 2024
DIMENSIONAL FUND ADVISORS LP2.16%0.00%304,109-53,506-14.96%465,287Jun 30, 2024
TWO SIGMA INVESTMENTS, LP0.14%0.00%19,330-13,100-40.39%29,575Jun 30, 2024
BANK OF NEW YORK MELLON CORP0.53%-75,268--115,160Jun 30, 2024
GEODE CAPITAL MANAGEMENT, LLC0.63%-88,7464,2245.00%135,801Jun 30, 2024
VANGUARD GROUP INC2.65%-374,251--572,604Jun 30, 2024
NORTHERN TRUST CORP0.12%-16,322-16-0.10%24,973,000Jun 30, 2024
BLACKROCK INC.0.78%-110,564--169,163Jun 30, 2024
UBS GROUP AG0.05%-6,8705,077283.16%10,511Jun 30, 2024
STATE STREET CORP0.24%-33,700--51,561,000Jun 30, 2024
ADVISOR GROUP HOLDINGS, INC.0.00%-100--153Jun 30, 2024
MORGAN STANLEY0.02%-2,660-8,614-76.41%4,070Jun 30, 2024
HUNTINGTON NATIONAL BANK--1--2Jun 30, 2024
BANK OF AMERICA CORP /DE/0.00%-6767100.00%103Jun 30, 2024

The largest Cumberland Pharmaceuticals shareholder by % of total assets is BRIDGEWAY CAPITAL MANAGEMENT, LLC. The company owns 286.65K shares of Cumberland Pharmaceuticals (CPIX), representing 0.01% of its total assets.

Institutional Buyers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
CRESSET ASSET MANAGEMENT, LLC0.15%0.00%21,0259,00074.84%32,168Jun 30, 2024
UBS GROUP AG0.05%-6,8705,077283.16%10,511Jun 30, 2024
GEODE CAPITAL MANAGEMENT, LLC0.63%-88,7464,2245.00%135,801Jun 30, 2024
INNEALTA CAPITAL, LLC0.01%0.00%948948100.00%1,450Jun 30, 2024
TOWER RESEARCH CAPITAL LLC (TRC)0.05%0.00%6,60886114.98%10,110Jun 30, 2024
BANK OF AMERICA CORP /DE/0.00%-6767100.00%103Jun 30, 2024
JPMORGAN CHASE & CO0.00%-20--31Jun 30, 2024
HUNTINGTON NATIONAL BANK--1--2Jun 30, 2024
ADVISOR GROUP HOLDINGS, INC.0.00%-100--153Jun 30, 2024
STATE STREET CORP0.24%-33,700--51,561,000Jun 30, 2024
BLACKROCK INC.0.78%-110,564--169,163Jun 30, 2024
VANGUARD GROUP INC2.65%-374,251--572,604Jun 30, 2024
BANK OF NEW YORK MELLON CORP0.53%-75,268--115,160Jun 30, 2024
OAKWORTH CAPITAL, INC.0.02%0.00%3,052--4,670Jun 30, 2024
ACADIAN ASSET MANAGEMENT LLC1.33%0.00%188,164--286,000Jun 30, 2024
BRIDGEWAY CAPITAL MANAGEMENT, LLC2.03%0.01%286,655--438,582Jun 30, 2024
NORTHERN TRUST CORP0.12%-16,322-16-0.10%24,973,000Jun 30, 2024
WELLS FARGO & COMPANY/MN----65-100.00%-Jun 30, 2024
RENAISSANCE TECHNOLOGIES LLC3.82%0.00%538,163-4,500-0.83%823,389Jun 30, 2024
MORGAN STANLEY0.02%-2,660-8,614-76.41%4,070Jun 30, 2024

As of Jun 30 2024, Cumberland Pharmaceuticals's largest institutional buyer is CRESSET ASSET MANAGEMENT, LLC. The company purchased 9.00K stocks of CPIX, valued at $32.17K.

Institutional Sellers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
DIMENSIONAL FUND ADVISORS LP2.16%0.00%304,109-53,506-14.96%465,287Jun 30, 2024
TWO SIGMA INVESTMENTS, LP0.14%0.00%19,330-13,100-40.39%29,575Jun 30, 2024
MORGAN STANLEY0.02%-2,660-8,614-76.41%4,070Jun 30, 2024
RENAISSANCE TECHNOLOGIES LLC3.82%0.00%538,163-4,500-0.83%823,389Jun 30, 2024
WELLS FARGO & COMPANY/MN----65-100.00%-Jun 30, 2024
NORTHERN TRUST CORP0.12%-16,322-16-0.10%24,973,000Jun 30, 2024
BRIDGEWAY CAPITAL MANAGEMENT, LLC2.03%0.01%286,655--438,582Jun 30, 2024
ACADIAN ASSET MANAGEMENT LLC1.33%0.00%188,164--286,000Jun 30, 2024
OAKWORTH CAPITAL, INC.0.02%0.00%3,052--4,670Jun 30, 2024
BANK OF NEW YORK MELLON CORP0.53%-75,268--115,160Jun 30, 2024
VANGUARD GROUP INC2.65%-374,251--572,604Jun 30, 2024
BLACKROCK INC.0.78%-110,564--169,163Jun 30, 2024
STATE STREET CORP0.24%-33,700--51,561,000Jun 30, 2024
ADVISOR GROUP HOLDINGS, INC.0.00%-100--153Jun 30, 2024
HUNTINGTON NATIONAL BANK--1--2Jun 30, 2024
JPMORGAN CHASE & CO0.00%-20--31Jun 30, 2024
BANK OF AMERICA CORP /DE/0.00%-6767100.00%103Jun 30, 2024
TOWER RESEARCH CAPITAL LLC (TRC)0.05%0.00%6,60886114.98%10,110Jun 30, 2024
INNEALTA CAPITAL, LLC0.01%0.00%948948100.00%1,450Jun 30, 2024
GEODE CAPITAL MANAGEMENT, LLC0.63%-88,7464,2245.00%135,801Jun 30, 2024

As of Jun 30 2024, Cumberland Pharmaceuticals's biggest institutional seller is DIMENSIONAL FUND ADVISORS LP. The company sold -53.51K shares of CPIX, valued at $465.29K.

Institutional New positions

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
INNEALTA CAPITAL, LLC0.01%0.00%948948100.00%1,450Jun 30, 2024

Cumberland Pharmaceuticals's largest new institutional shareholder by number of shares is INNEALTA CAPITAL, LLC, purchased 948.00 shares, valued at $1.45K, as of undefined.

Institutional Sold Out

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
WELLS FARGO & COMPANY/MN----65-100.00%-Jun 30, 2024

Cumberland Pharmaceuticals's largest sold out institutional shareholder by shares sold is WELLS FARGO & COMPANY/MN, sold -65.00 shares, valued at -, as of undefined.

Cumberland Pharmaceuticals Mutual Fund Holders


Name% Total AssetsTotal SharesChange AmountChange %Date
BRIDGEWAY FUNDS INC0.12%282,955--Mar 28, 2024
Vericimetry Funds0.04%3,950--Mar 31, 2024
VANGUARD VALLEY FORGE FUNDS0.02%9,187--Mar 31, 2024
DIMENSIONAL INVESTMENT GROUP INC0.00%23,319--Jan 31, 2024
VANGUARD INDEX FUNDS0.00%365,064-84,244-18.75%Mar 31, 2024
FIDELITY CONCORD STREET TRUST0.00%79,935-1,064-1.31%Feb 29, 2024
Dimensional ETF Trust0.00%92,047-1,200-1.29%Jan 31, 2024
DFA INVESTMENT DIMENSIONS GROUP INC0.00%204,192-4,400-2.11%Jan 31, 2024
DFA INVESTMENT TRUST CO0.00%23,319--Jan 31, 2024
VANGUARD INSTITUTIONAL INDEX FUNDS0.00%3,993--Mar 31, 2024
VALIC Co I0.00%27,800--Feb 29, 2024
HC CAPITAL TRUST0.00%3,000--Mar 31, 2024
ALLIANZ VARIABLE INSURANCE PRODUCTS TRUST0.00%4,883--Dec 31, 2023
NORTHERN LIGHTS FUND TRUST II0.00%944--Mar 31, 2024
SA FUNDS INVESTMENT TRUST0.00%1,100--Mar 31, 2024
Segall Bryant & Hamill Trust0.00%1,244--Mar 31, 2024
NATIONWIDE MUTUAL FUNDS0.00%2,281--Jan 31, 2024
USAA MUTUAL FUNDS TRUST0.00%915--Jan 31, 2024
Blackstone Alternative Investment Funds0.00%300--Mar 31, 2024
NORTHERN FUNDS0.00%232--Mar 28, 2024
JOHN HANCOCK VARIABLE INSURANCE TRUST0.00%956--Mar 31, 2024
EQ ADVISORS TRUST0.00%403--Mar 31, 2024

Cumberland Pharmaceuticals's largest mutual fund holder by % of total assets is "BRIDGEWAY FUNDS INC", owning 282.95K shares, compromising 0.12% of its total assets.

Cumberland Pharmaceuticals Institutional Ownership Trends


Institutional Holdings Trend

DateHoldingsChange %
30 Jun, 249-62.50%
31 Mar, 2424-4.00%
31 Dec, 232513.64%
30 Sep, 2322-8.33%
30 Jun, 23244.35%
31 Mar, 2323-
31 Dec, 222353.33%
30 Sep, 2215-31.82%
30 Jun, 2222-15.38%
31 Mar, 22268.33%
31 Dec, 212420.00%
30 Sep, 2120-23.08%
30 Jun, 2126-10.34%
31 Mar, 212916.00%
31 Dec, 20254.17%
30 Sep, 2024-7.69%
30 Jun, 202613.04%
31 Mar, 2023-14.81%
31 Dec, 1927-
30 Sep, 192722.73%
30 Jun, 1922-4.35%
31 Mar, 1923-8.00%
31 Dec, 1825-19.35%
30 Sep, 18316.90%
30 Jun, 1829-
31 Mar, 1829-6.45%
31 Dec, 1731-3.13%
30 Sep, 1732-5.88%
30 Jun, 1734-5.56%
31 Mar, 1736-10.00%
31 Dec, 1640-2.44%
30 Sep, 1641-6.82%
30 Jun, 1644-4.35%
31 Mar, 16462.22%
31 Dec, 1545-2.17%
30 Sep, 15462.22%
30 Jun, 1545-
31 Mar, 15454.65%
31 Dec, 1443-2.27%
30 Sep, 1444-
30 Jun, 1444-4.35%
31 Mar, 14464.55%
31 Dec, 1344-2.22%
30 Sep, 1345-21.05%
30 Jun, 1357185.00%
31 Mar, 1320-16.67%
31 Dec, 122420.00%
30 Sep, 1220-9.09%
30 Jun, 122215.79%
31 Mar, 121958.33%
31 Dec, 111220.00%
30 Sep, 111011.11%
30 Jun, 119-47.06%
31 Mar, 111730.77%
31 Dec, 1013-23.53%
30 Sep, 1017-15.00%
30 Jun, 102066.67%
31 Mar, 101220.00%
31 Dec, 0910-
30 Sep, 0910-

As of 30 Jun 24, 9 institutions are holding Cumberland Pharmaceuticals's shares, representing a decrease of -62.50% compared to the previous quarter.

Shares Outstanding Trend

DateShares OutstandingChange %
30 Jun, 241,198,471-44.59%
31 Mar, 242,162,869-1.58%
31 Dec, 232,197,513-0.47%
30 Sep, 232,207,792-7.97%
30 Jun, 232,399,099-1.97%
31 Mar, 232,447,305-1.83%
31 Dec, 222,493,0071.91%
30 Sep, 222,446,389-9.68%
30 Jun, 222,708,573-6.56%
31 Mar, 222,898,6682.24%
31 Dec, 212,835,2622.43%
30 Sep, 212,767,954-5.84%
30 Jun, 212,939,579-8.88%
31 Mar, 213,225,928-16.77%
31 Dec, 203,875,859-3.83%
30 Sep, 204,030,397-2.71%
30 Jun, 204,142,481-11.38%
31 Mar, 204,674,6642.74%
31 Dec, 194,549,8731.52%
30 Sep, 194,481,884-6.02%
30 Jun, 194,768,946-3.18%
31 Mar, 194,925,636-1.22%
31 Dec, 184,986,368-6.92%
30 Sep, 185,356,908-0.16%
30 Jun, 185,365,571-1.10%
31 Mar, 185,425,411-0.10%
31 Dec, 175,430,7220.17%
30 Sep, 175,421,470-0.52%
30 Jun, 175,449,831-1.02%
31 Mar, 175,506,192-1.64%
31 Dec, 165,598,2523.36%
30 Sep, 165,416,4883.35%
30 Jun, 165,240,6820.49%
31 Mar, 165,215,0451.69%
31 Dec, 155,128,605-46.74%
30 Sep, 159,629,75085.14%
30 Jun, 155,201,454-5.53%
31 Mar, 155,505,920-3.69%
31 Dec, 145,716,848-10.07%
30 Sep, 146,357,061-4.70%
30 Jun, 146,670,341-0.72%
31 Mar, 146,719,046-1.44%
31 Dec, 136,817,2044.89%
30 Sep, 136,499,624-0.67%
30 Jun, 136,543,562228.14%
31 Mar, 131,994,163-19.54%
31 Dec, 122,478,398-17.42%
30 Sep, 123,001,31420.59%
30 Jun, 122,488,90816.57%
31 Mar, 122,135,13115.65%
31 Dec, 111,846,181-26.07%
30 Sep, 112,497,1378.18%
30 Jun, 112,308,363-0.75%
31 Mar, 112,325,91816.23%
31 Dec, 102,001,165-16.59%
30 Sep, 102,399,1434.69%
30 Jun, 102,291,658102.50%
31 Mar, 101,131,699-4.32%
31 Dec, 091,182,80717.46%
30 Sep, 091,006,967-

Cumberland Pharmaceuticals (CPIX) has 1.20M shares outstanding as of 30 Jun 24, down -44.59% compared to the previous quarter.

Institutional Ownership Trend

DateOwnership %Change %
30 Jun, 248.50%3.72%
31 Mar, 2415.13%6.39%
31 Dec, 2315.39%6.54%
30 Sep, 2315.34%5.50%
30 Jun, 2316.71%5.75%
31 Mar, 2317.04%5.69%
31 Dec, 2217.31%6.06%
30 Sep, 2216.90%4.97%
30 Jun, 2218.44%4.74%
31 Mar, 2219.73%5.38%
31 Dec, 2119.16%5.54%
30 Sep, 2118.60%4.83%
30 Jun, 2119.63%4.23%
31 Mar, 2121.54%3.30%
31 Dec, 2025.56%3.60%
30 Sep, 2026.63%3.60%
30 Jun, 2027.18%2.89%
31 Mar, 2030.67%3.51%
31 Dec, 1929.55%3.47%
30 Sep, 1929.16%3.09%
30 Jun, 1930.72%3.03%
31 Mar, 1931.83%3.08%
31 Dec, 1832.13%2.71%
30 Sep, 1834.40%2.94%
30 Jun, 1834.23%2.86%
31 Mar, 1834.58%2.97%
31 Dec, 1734.13%2.92%
30 Sep, 1734.17%2.95%
30 Jun, 1734.04%2.89%
31 Mar, 1734.32%2.85%
31 Dec, 1634.68%3.11%
30 Sep, 1633.40%3.21%
30 Jun, 1632.26%3.17%
31 Mar, 1631.91%3.39%
31 Dec, 1530.68%0.91%
30 Sep, 1557.99%6.06%
30 Jun, 1530.92%2.95%
31 Mar, 1532.36%3.07%
31 Dec, 1432.45%2.47%
30 Sep, 1436.23%2.56%
30 Jun, 1437.59%2.67%
31 Mar, 1437.52%2.71%
31 Dec, 1337.19%2.93%
30 Sep, 1335.65%2.82%
30 Jun, 1335.55%31.46%
31 Mar, 1310.63%6.62%
31 Dec, 1212.67%5.31%
30 Sep, 1215.44%9.75%
30 Jun, 1212.59%11.05%
31 Mar, 1210.67%12.96%
31 Dec, 119.08%6.01%
30 Sep, 1112.28%9.66%
30 Jun, 1111.28%8.71%
31 Mar, 1111.38%11.75%
31 Dec, 109.84%7.07%
30 Sep, 1011.80%9.39%
30 Jun, 1011.21%35.83%
31 Mar, 105.59%8.06%
31 Dec, 098.33%20.37%
30 Sep, 096.40%-

As of 30 Jun 24, Cumberland Pharmaceuticals is held by 8.50% institutional shareholders, representing a 3.72% growth compared to 31 Mar 24.

Institutional Increased Positions Trend

DateIncreased PositionsChange %
30 Jun, 242-60.00%
31 Mar, 245-37.50%
31 Dec, 23860.00%
30 Sep, 235-16.67%
30 Jun, 236-
31 Mar, 236-45.45%
31 Dec, 2211450.00%
30 Sep, 222-77.78%
30 Jun, 229-40.00%
31 Mar, 221525.00%
31 Dec, 2112100.00%
30 Sep, 21650.00%
30 Jun, 214-63.64%
31 Mar, 211157.14%
31 Dec, 207-
30 Sep, 207-41.67%
30 Jun, 201271.43%
31 Mar, 207-22.22%
31 Dec, 199-10.00%
30 Sep, 191011.11%
30 Jun, 19928.57%
31 Mar, 19740.00%
31 Dec, 185-61.54%
30 Sep, 181318.18%
30 Jun, 1811-
31 Mar, 1811-21.43%
31 Dec, 171455.56%
30 Sep, 179-30.77%
30 Jun, 1713-7.14%
31 Mar, 1714-12.50%
31 Dec, 161623.08%
30 Sep, 1613-18.75%
30 Jun, 161614.29%
31 Mar, 161416.67%
31 Dec, 1512-14.29%
30 Sep, 1514-22.22%
30 Jun, 1518-
31 Mar, 1518-5.26%
31 Dec, 141990.00%
30 Sep, 1410-
30 Jun, 1410-52.38%
31 Mar, 142131.25%
31 Dec, 13166.67%
30 Sep, 1315-66.67%
30 Jun, 1345309.09%
31 Mar, 1311-15.38%
31 Dec, 12138.33%
30 Sep, 1212-25.00%
30 Jun, 121623.08%
31 Mar, 121385.71%
31 Dec, 11716.67%
30 Sep, 11620.00%
30 Jun, 115-28.57%
31 Mar, 117-
31 Dec, 107-
30 Sep, 107-61.11%
30 Jun, 1018125.00%
31 Mar, 10814.29%
31 Dec, 097-30.00%
30 Sep, 0910-

2 institutional shareholders have increased their position in CPIX stock as of 30 Jun 24 compared to 5 in the previous quarter (a -60.00% decrease).

Institutional Reduced Positions Trend

DateReduced PositionsChange %
30 Jun, 242-77.78%
31 Mar, 24950.00%
31 Dec, 236-
30 Sep, 236-14.29%
30 Jun, 237-12.50%
31 Mar, 23833.33%
31 Dec, 22620.00%
30 Sep, 225-50.00%
30 Jun, 2210100.00%
31 Mar, 225-28.57%
31 Dec, 21740.00%
30 Sep, 215-50.00%
30 Jun, 211042.86%
31 Mar, 217-22.22%
31 Dec, 20950.00%
30 Sep, 20620.00%
30 Jun, 205-16.67%
31 Mar, 206-14.29%
31 Dec, 197-30.00%
30 Sep, 191066.67%
30 Jun, 196-33.33%
31 Mar, 199-10.00%
31 Dec, 181042.86%
30 Sep, 187-
30 Jun, 187-30.00%
31 Mar, 181011.11%
31 Dec, 179-25.00%
30 Sep, 171250.00%
30 Jun, 17814.29%
31 Mar, 177-46.15%
31 Dec, 1613-
30 Sep, 161344.44%
30 Jun, 169-40.00%
31 Mar, 1615-16.67%
31 Dec, 151828.57%
30 Sep, 15147.69%
30 Jun, 1513-
31 Mar, 151344.44%
31 Dec, 149-47.06%
30 Sep, 14176.25%
30 Jun, 141633.33%
31 Mar, 1412-33.33%
31 Dec, 1318-10.00%
30 Sep, 1320233.33%
30 Jun, 13620.00%
31 Mar, 135-28.57%
31 Dec, 127133.33%
30 Sep, 12350.00%
30 Jun, 122-33.33%
31 Mar, 123-25.00%
31 Dec, 11433.33%
30 Sep, 113-
30 Jun, 113-40.00%
31 Mar, 11566.67%
31 Dec, 103-25.00%
30 Sep, 104300.00%
30 Jun, 101-50.00%
31 Mar, 102-33.33%
31 Dec, 093-
30 Sep, 09--

2 institutional shareholders have reduced their position in CPIX stock as of 30 Jun 24 compared to 9 in the previous quarter (a -77.78% decrease).

All Institutional Ownership Trend Data

DateHoldingsChange %Shares OutstandingChange %Ownership %Change %Increased PositionsChange %Reduced PositionsChange %
30 Jun, 249-62.50%1,198,471-44.59%8.50%3.72%2-60.00%2-77.78%
31 Mar, 2424-4.00%2,162,869-1.58%15.13%6.39%5-37.50%950.00%
31 Dec, 232513.64%2,197,513-0.47%15.39%6.54%860.00%6-
30 Sep, 2322-8.33%2,207,792-7.97%15.34%5.50%5-16.67%6-14.29%
30 Jun, 23244.35%2,399,099-1.97%16.71%5.75%6-7-12.50%
31 Mar, 2323-2,447,305-1.83%17.04%5.69%6-45.45%833.33%
31 Dec, 222353.33%2,493,0071.91%17.31%6.06%11450.00%620.00%
30 Sep, 2215-31.82%2,446,389-9.68%16.90%4.97%2-77.78%5-50.00%
30 Jun, 2222-15.38%2,708,573-6.56%18.44%4.74%9-40.00%10100.00%
31 Mar, 22268.33%2,898,6682.24%19.73%5.38%1525.00%5-28.57%
31 Dec, 212420.00%2,835,2622.43%19.16%5.54%12100.00%740.00%
30 Sep, 2120-23.08%2,767,954-5.84%18.60%4.83%650.00%5-50.00%
30 Jun, 2126-10.34%2,939,579-8.88%19.63%4.23%4-63.64%1042.86%
31 Mar, 212916.00%3,225,928-16.77%21.54%3.30%1157.14%7-22.22%
31 Dec, 20254.17%3,875,859-3.83%25.56%3.60%7-950.00%
30 Sep, 2024-7.69%4,030,397-2.71%26.63%3.60%7-41.67%620.00%
30 Jun, 202613.04%4,142,481-11.38%27.18%2.89%1271.43%5-16.67%
31 Mar, 2023-14.81%4,674,6642.74%30.67%3.51%7-22.22%6-14.29%
31 Dec, 1927-4,549,8731.52%29.55%3.47%9-10.00%7-30.00%
30 Sep, 192722.73%4,481,884-6.02%29.16%3.09%1011.11%1066.67%
30 Jun, 1922-4.35%4,768,946-3.18%30.72%3.03%928.57%6-33.33%
31 Mar, 1923-8.00%4,925,636-1.22%31.83%3.08%740.00%9-10.00%
31 Dec, 1825-19.35%4,986,368-6.92%32.13%2.71%5-61.54%1042.86%
30 Sep, 18316.90%5,356,908-0.16%34.40%2.94%1318.18%7-
30 Jun, 1829-5,365,571-1.10%34.23%2.86%11-7-30.00%
31 Mar, 1829-6.45%5,425,411-0.10%34.58%2.97%11-21.43%1011.11%
31 Dec, 1731-3.13%5,430,7220.17%34.13%2.92%1455.56%9-25.00%
30 Sep, 1732-5.88%5,421,470-0.52%34.17%2.95%9-30.77%1250.00%
30 Jun, 1734-5.56%5,449,831-1.02%34.04%2.89%13-7.14%814.29%
31 Mar, 1736-10.00%5,506,192-1.64%34.32%2.85%14-12.50%7-46.15%
31 Dec, 1640-2.44%5,598,2523.36%34.68%3.11%1623.08%13-
30 Sep, 1641-6.82%5,416,4883.35%33.40%3.21%13-18.75%1344.44%
30 Jun, 1644-4.35%5,240,6820.49%32.26%3.17%1614.29%9-40.00%
31 Mar, 16462.22%5,215,0451.69%31.91%3.39%1416.67%15-16.67%
31 Dec, 1545-2.17%5,128,605-46.74%30.68%0.91%12-14.29%1828.57%
30 Sep, 15462.22%9,629,75085.14%57.99%6.06%14-22.22%147.69%
30 Jun, 1545-5,201,454-5.53%30.92%2.95%18-13-
31 Mar, 15454.65%5,505,920-3.69%32.36%3.07%18-5.26%1344.44%
31 Dec, 1443-2.27%5,716,848-10.07%32.45%2.47%1990.00%9-47.06%
30 Sep, 1444-6,357,061-4.70%36.23%2.56%10-176.25%
30 Jun, 1444-4.35%6,670,341-0.72%37.59%2.67%10-52.38%1633.33%
31 Mar, 14464.55%6,719,046-1.44%37.52%2.71%2131.25%12-33.33%
31 Dec, 1344-2.22%6,817,2044.89%37.19%2.93%166.67%18-10.00%
30 Sep, 1345-21.05%6,499,624-0.67%35.65%2.82%15-66.67%20233.33%
30 Jun, 1357185.00%6,543,562228.14%35.55%31.46%45309.09%620.00%
31 Mar, 1320-16.67%1,994,163-19.54%10.63%6.62%11-15.38%5-28.57%
31 Dec, 122420.00%2,478,398-17.42%12.67%5.31%138.33%7133.33%
30 Sep, 1220-9.09%3,001,31420.59%15.44%9.75%12-25.00%350.00%
30 Jun, 122215.79%2,488,90816.57%12.59%11.05%1623.08%2-33.33%
31 Mar, 121958.33%2,135,13115.65%10.67%12.96%1385.71%3-25.00%
31 Dec, 111220.00%1,846,181-26.07%9.08%6.01%716.67%433.33%
30 Sep, 111011.11%2,497,1378.18%12.28%9.66%620.00%3-
30 Jun, 119-47.06%2,308,363-0.75%11.28%8.71%5-28.57%3-40.00%
31 Mar, 111730.77%2,325,91816.23%11.38%11.75%7-566.67%
31 Dec, 1013-23.53%2,001,165-16.59%9.84%7.07%7-3-25.00%
30 Sep, 1017-15.00%2,399,1434.69%11.80%9.39%7-61.11%4300.00%
30 Jun, 102066.67%2,291,658102.50%11.21%35.83%18125.00%1-50.00%
31 Mar, 101220.00%1,131,699-4.32%5.59%8.06%814.29%2-33.33%
31 Dec, 0910-1,182,80717.46%8.33%20.37%7-30.00%3-
30 Sep, 0910-1,006,967-6.40%-10---

Cumberland Pharmaceuticals Insider Shareholders Trades


Open Market Insider Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource

Open Market Insider Buys

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource

Insider Sells

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource

All Insider Owners Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Aug 02, 2024Krogulski Kennethdirector-L-SmallBuy221$1.45$320.45247,907
Aug 02, 2024Krogulski Kennethdirector-L-SmallBuy66$1.48$97.68247,686
Aug 02, 2024Krogulski Kennethdirector-L-SmallBuy221$1.49$329.29247,620
Aug 02, 2024Krogulski Kennethdirector-L-SmallBuy221$1.50$331.50247,399
Aug 02, 2024Krogulski Kennethdirector-L-SmallBuy167$1.49$248.83247,178
Aug 02, 2024Krogulski Kennethdirector-L-SmallBuy221$1.50$331.50247,011
Aug 02, 2024Krogulski Kennethdirector-L-SmallBuy221$1.50$331.50246,790
Aug 02, 2024Krogulski Kennethdirector-L-SmallBuy221$1.49$329.29246,569
Aug 02, 2024Krogulski Kennethdirector-L-SmallBuy134$1.48$198.32246,348
Aug 02, 2024Krogulski Kennethdirector-L-SmallBuy221$1.48$327.08246,214
Aug 02, 2024Krogulski Kennethdirector-L-SmallBuy66$1.45$95.70245,993
Aug 02, 2024Krogulski Kennethdirector-L-SmallBuy200$1.50$300.00245,927
Aug 02, 2024Krogulski Kennethdirector-L-SmallBuy221$1.48$327.08245,727
Aug 02, 2024Krogulski Kennethdirector-L-SmallBuy134$1.49$199.66245,506
Aug 02, 2024Krogulski Kennethdirector-L-SmallBuy221$1.47$324.87245,372
Aug 02, 2024Krogulski Kennethdirector-L-SmallBuy221$1.50$331.50245,151
Aug 02, 2024Krogulski Kennethdirector-L-SmallBuy221$1.50$331.50244,930
Aug 02, 2024Krogulski Kennethdirector-L-SmallBuy221$1.49$329.29244,709
Aug 02, 2024Krogulski Kennethdirector-L-SmallBuy221$1.50$331.50244,488
Aug 02, 2024Krogulski Kennethdirector-L-SmallBuy268$1.52$407.36244,267

Cumberland Pharmaceuticals Insider Ownership Trends


All Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q1 2026-2-
Q1 2025-3-
Q3 202488--
Q2 202444--
Q1 2024105200.00%
Q4 2023228122800.00%
Q3 2023124--
Q1 2023105200.00%
Q4 2022227--
Q3 2022132113200.00%
Q2 2022213210650.00%
Q1 2022104250.00%
Q4 2021304--
Q3 2021370--
Q2 202121437133.33%
Q1 2021126200.00%
Q4 2020---
Q3 20209--
Q2 202033--
Q1 2020115220.00%

0 total buy trades, and 2 total sell trades (buy/sell ratio of 0.00%) were made by Cumberland Pharmaceuticals's insiders, as of Q1 2026.

Open Market Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q1 2026---
Q1 2025---
Q3 2024---
Q2 2024---
Q1 2024---
Q4 2023---
Q3 2023---
Q1 2023---
Q4 2022227--
Q3 2022132--
Q2 2022213--
Q1 2022---
Q4 2021304--
Q3 2021370--
Q2 2021161--
Q1 2021---
Q4 2020---
Q3 20209--
Q2 202033--
Q1 2020---

As of Q1 2026, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Cumberland Pharmaceuticals's stocks.

Cumberland Pharmaceuticals Peer Ownership


TickerCompany
AKANAkanda Corp.
BFRIBiofrontera Inc.
EVOKEvoke Pharma, Inc.
LFCRLifecore Biomedical, Inc.
ORGOOrganogenesis Holdings Inc.
GHSIGuardion Health Sciences, Inc.
RGCRegencell Bioscience Holdings Limited
IXHLIncannex Healthcare Limited
IRWDIronwood Pharmaceuticals, Inc.
ALIMAlimera Sciences, Inc.
SHPHShuttle Pharmaceuticals Holdings, Inc.
PTPIPetros Pharmaceuticals, Inc.
PROCProcaps Group S.A.
LSDILucy Scientific Discovery Inc.
PRFXPainReform Ltd.
AGRXAgile Therapeutics, Inc.
KMDAKamada Ltd.
EGRXEagle Pharmaceuticals, Inc.

CPIX Ownership FAQ


Cumberland Pharmaceuticals is owned by institutional shareholders (8.50%), insiders (44.47%), and public (47.03%). The largest institutional shareholder of Cumberland Pharmaceuticals is RENAISSANCE TECHNOLOGIES LLC (3.82% of total shares) and the top mutual fund owner is BRIDGEWAY FUNDS INC (0.12% of total shares).

Cumberland Pharmaceuticals's major institutional shareholders are RENAISSANCE TECHNOLOGIES LLC, VANGUARD GROUP INC, DIMENSIONAL FUND ADVISORS LP, BRIDGEWAY CAPITAL MANAGEMENT, LLC, and ACADIAN ASSET MANAGEMENT LLC. The top five shareholders own together 12.00% of the company's share outstanding.

As of Jun 2024, there are 9 institutional shareholders of Cumberland Pharmaceuticals.

RENAISSANCE TECHNOLOGIES LLC owns 538.16K shares of Cumberland Pharmaceuticals, representing 3.82% of the company's total shares outstanding, valued at $823.39K (as of Jun 2024).

As of Jun 2024, VANGUARD GROUP INC holds 374.25K shares of Cumberland Pharmaceuticals (CPIX), compromising 2.65% of the company, valued at $572.6K.

DIMENSIONAL FUND ADVISORS LP is the third largest holder of Cumberland Pharmaceuticals. The company owns 304.11K of the company's shares outstanding (worth $465.29K).